Zimmer Biomet Holdings Q2 2024 Adj. EPS $2.01 Beats $1.99 Estimate, Sales $1.942B Beat $1.941B Estimate
Portfolio Pulse from Benzinga Newsdesk
Zimmer Biomet Holdings (NYSE:ZBH) reported Q2 2024 adjusted EPS of $2.01, beating the $1.99 estimate. Sales were $1.942 billion, slightly above the $1.941 billion estimate. EPS increased by 10.44% year-over-year, and sales grew by 3.85%.
August 07, 2024 | 10:31 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Zimmer Biomet Holdings reported Q2 2024 adjusted EPS of $2.01, beating the $1.99 estimate. Sales were $1.942 billion, slightly above the $1.941 billion estimate. EPS increased by 10.44% year-over-year, and sales grew by 3.85%.
The company's earnings and sales both beat analyst estimates, which is generally positive for the stock price. The year-over-year growth in EPS and sales further supports a positive outlook.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100